A total of 225 health care providers and health systems want to tap into the New Jersey Prescription Monitoring Program, a statewide database that automatically supplies doctors and pharmacists with information on a patient’s prescriptions for controlled dangerous substances, including opioids. The requests will double the number of medical facilities that can access the program.
The database is operated by the Division of Consumer Affairs. It collects information from pharmacies that dispense controlled substances to patients, creating a record so health care providers can understand a patient’s full prescription drug history. The tool aims to improve prescribing practices, target treatment to at-risk patients and mitigate the risk of potential abuse or fraud by patients who obtain prescriptions from multiple providers.
The uptick in interest in the monitoring program follows an announcement made five weeks ago by Attorney General Gurbir S. Grewal that $1.2 million in federal funding had been made available to integrate electronic health records and pharmacy management systems statewide.